Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2004-02-12
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 160
- Registration Number
- NCT00077311
- Locations
- 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Veterans Affairs Medical Center - Baltimore, Baltimore, Maryland, United States
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
- Conditions
- First Posted Date
- 2004-02-11
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT00077103
- Locations
- 🇺🇸
Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)
- Conditions
- Interventions
- First Posted Date
- 2004-02-11
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 1
- Registration Number
- NCT00077051
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer
- Conditions
- First Posted Date
- 2004-02-09
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Lombardi Comprehensive Cancer Center
- Registration Number
- NCT00003108
- Locations
- 🇺🇸
Lombardi Cancer Center, Washington, District of Columbia, United States
Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
- Conditions
- First Posted Date
- 2004-02-09
- Last Posted Date
- 2020-07-14
- Target Recruit Count
- 12
- Registration Number
- NCT00003086
- Locations
- 🇺🇸
Louisiana State University School of Medicine, Shreveport, Louisiana, United States
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
- First Posted Date
- 2004-02-09
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 253
- Registration Number
- NCT00003937
- Locations
- 🇺🇸
St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
- Conditions
- First Posted Date
- 2004-02-04
- Last Posted Date
- 2012-01-10
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00020696
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
🇺🇸Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
- First Posted Date
- 2004-02-03
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 53
- Registration Number
- NCT00006111
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
🇫🇷Centre Leon Berard, Lyon, France
🇫🇷Institut Sainte Catherine, Avignon, France
Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-01-29
- Last Posted Date
- 2013-11-03
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 64
- Registration Number
- NCT00005022
- Locations
- 🇺🇸
Northwest Community Hospital, Arlington Heights, Illinois, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
- Conditions
- First Posted Date
- 2004-01-29
- Last Posted Date
- 2018-07-09
- Target Recruit Count
- 359
- Registration Number
- NCT00003888
- Locations
Institute of Oncology and Radiology of Serbia, Belgrade, Former Yugoslavia
🇫🇷CHR de Besancon - Hopital Jean Minjoz, Besancon, France
🇫🇷Centre Hospital Regional Universitaire de Limoges, Limoges, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.